Valuation: Krka, d. d.

Market Cap 7.97B 9.11B 7.35B 6.79B 12.88B 869B 13.1B 87.82B 34.49B 428B 34.21B 33.46B 1,471B P/E 2026 *
19x
P/E 2027 * 18x
Enterprise Value 7.29B 8.33B 6.72B 6.21B 11.78B 795B 11.98B 80.33B 31.54B 392B 31.29B 30.61B 1,346B EV / Sales 2026 *
3.36x
EV / Sales 2027 * 3.16x
Free-Float
74.74%
Yield 2026 *
3.5%
Yield 2027 * 3.86%
1 day+0.86%
1 week+1.75%
Current month+4.59%
1 month+2.34%
3 months+11.02%
6 months+22.43%
Current year+29.06%
1 week 260
Extreme 260
265
1 month 249.5
Extreme 249.5
267.5
Current year 202
Extreme 202
267.5
1 year 174
Extreme 174
267.5
3 years 100
Extreme 100
267.5
5 years 80
Extreme 80
267.5
10 years 48.01
Extreme 48.01
267.5
Manager TitleAgeSince
Chief Executive Officer 70 2004-12-31
Director of Finance/CFO - 1996-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 2008-12-31
Director/Board Member 59 2004-12-31
Director/Board Member 59 2004-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%+1.75%+34.02%+123.93% 9.11B
-0.17%+3.45%+15.94%+86.88% 48.73B
+1.04%-3.54%+67.29%+114.44% 35.82B
-0.13%-1.14%-3.51%+41.03% 12.2B
-0.71%+4.64%+17.61%+97.65% 12.11B
-0.86%+1.08%+53.57%-3.92% 7.09B
+0.75%-0.82%+17.49%+44.79% 7B
+0.69%+3.96%+25.52%+231.22% 6.7B
+5.45%+1.89%-18.02%+13.55% 5.78B
+1.24%+0.10%+27.46%+135.60% 4.33B
Average +0.82%+0.16%+23.74%+88.52% 14.89B
Weighted average by Cap. +0.45%+0.46%+29.26%+91.66%

Financials

2026 *2027 *
Net sales 2.17B 2.48B 2B 1.85B 3.5B 236B 3.56B 23.87B 9.37B 116B 9.3B 9.1B 400B 2.3B 2.63B 2.12B 1.96B 3.72B 251B 3.78B 25.33B 9.95B 123B 9.87B 9.65B 424B
Net income 420M 480M 387M 358M 678M 45.76B 690M 4.62B 1.82B 22.54B 1.8B 1.76B 77.49B 442M 505M 407M 376M 714M 48.17B 726M 4.87B 1.91B 23.73B 1.9B 1.86B 81.58B
Net Debt -680M -777M -627M -579M -1.1B -74.14B -1.12B -7.49B -2.94B -36.53B -2.92B -2.86B -126B -708M -809M -653M -603M -1.14B -77.17B -1.16B -7.8B -3.06B -38.02B -3.04B -2.97B -131B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,204
Date Price Change Volume
26-07-07 262.00 -0.76% 7,397
26-07-10 €260.00 -1.14% 8,080
26-07-09 €263.00 +0.38% 3,515
26-07-08 €262.00 -0.76% 7,397
26-07-07 €264.00 +1.15% 2,220
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
260.00EUR
Average target price
242.65EUR
Spread / Average Target
-6.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock